mlys

Mineralys Therapeutics, Inc. Rings the Closing Bell

Date & Time
Location

About This Event

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Jon Congleton, CEO of Mineralys, rings the Closing Bell.

Nasdaq watch

See what's playing at Nasdaq

WATCH NOW ->